OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NURI57

Nur Ink Innovations Ltd

Specialty ChemicalsVerified

Nur Ink Innovations Ltd has a liquidity position characterized by a current ratio of 2.29, indicating the company can cover its short-term liabilities with its short-term assets. The company holds cash and equivalents of ILS 3.86 million, which is a significant portion of its total assets of ILS 22.74 million. However, the company's operating cash flow is negative at ILS -7.53 million, and its free cash flow is also negative at ILS -11.61 million, suggesting ongoing cash outflows from operations. Profitability metrics for Nur Ink Innovations Ltd are negative, with a return on equity of -55.71% and a return on assets of -41.41%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. The company's operating income is negative at ILS -8.81 million, and its net income is also negative at ILS -9.42 million. These results are below the typical performance of the Specialty Chemicals industry, which generally expects positive returns and profitability. The company's revenue is concentrated in a single business segment, as it specializes in the development and production of functional water-based pigmented inks. There is no disclosed geographic diversification in the financial data, and the company's operations are based in Israel. This concentration may expose the company to specific market and regulatory risks in the region. Nur Ink Innovations Ltd's growth trajectory is not clearly defined in the provided data, as there is no historical revenue data to compare against the current revenue of ILS 327,000. The company's capital expenditures of ILS -4.02 million suggest ongoing investment in its operations, but the negative free cash flow indicates that these investments are not yet generating positive returns. The company's future growth will depend on its ability to increase revenue and improve profitability. The risk assessment for Nur Ink Innovations Ltd indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.13, suggesting a relatively low level of leverage. However, the company's negative operating and net income, along with negative cash flows, may pose challenges in maintaining its current capital structure without additional financing. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial position. The company's focus on research, development, and production of functional inks suggests a long-term strategy, but the current financial performance does not reflect this.

30-day price · NURI+101.10 (+11.6%)
Low$767.40High$1042.00Close$969.00As of15 May, 00:00 UTC
Profile
CompanyNur Ink Innovations Ltd
TickerNURI.TA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Nur Ink Innovations Ltd develops and produces functional water-based pigmented inks for digital inkjet printing applications, including Direct-to-Garment (DTG), Direct-to-Textile (DTT), and Roll-to-roll printing.

Classification. Nur Ink Innovations Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Nur Ink Innovations Ltd has a liquidity position characterized by a current ratio of 2.29, indicating the company can cover its short-term liabilities with its short-term assets. The company holds cash and equivalents of ILS 3.86 million, which is a significant portion of its total assets of ILS 22.74 million. However, the company's operating cash flow is negative at ILS -7.53 million, and its free cash flow is also negative at ILS -11.61 million, suggesting ongoing cash outflows from operations. Profitability metrics for Nur Ink Innovations Ltd are negative, with a return on equity of -55.71% and a return on assets of -41.41%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. The company's operating income is negative at ILS -8.81 million, and its net income is also negative at ILS -9.42 million. These results are below the typical performance of the Specialty Chemicals industry, which generally expects positive returns and profitability. The company's revenue is concentrated in a single business segment, as it specializes in the development and production of functional water-based pigmented inks. There is no disclosed geographic diversification in the financial data, and the company's operations are based in Israel. This concentration may expose the company to specific market and regulatory risks in the region. Nur Ink Innovations Ltd's growth trajectory is not clearly defined in the provided data, as there is no historical revenue data to compare against the current revenue of ILS 327,000. The company's capital expenditures of ILS -4.02 million suggest ongoing investment in its operations, but the negative free cash flow indicates that these investments are not yet generating positive returns. The company's future growth will depend on its ability to increase revenue and improve profitability. The risk assessment for Nur Ink Innovations Ltd indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.13, suggesting a relatively low level of leverage. However, the company's negative operating and net income, along with negative cash flows, may pose challenges in maintaining its current capital structure without additional financing. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial position. The company's focus on research, development, and production of functional inks suggests a long-term strategy, but the current financial performance does not reflect this.
Key takeaways
  • Nur Ink Innovations Ltd is experiencing negative profitability with a return on equity of -55.71% and a return on assets of -41.41%.
  • The company's liquidity position is relatively strong with a current ratio of 2.29, but its operating and free cash flows are negative.
  • Revenue is concentrated in a single business segment, and there is no disclosed geographic diversification.
  • The company's capital expenditures suggest ongoing investment, but the negative free cash flow indicates that these investments are not yet generating positive returns.
  • Risk assessment indicates low liquidity and dilution risk, but the company's financial performance may require additional financing.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyILS
Revenue$327.0k
Gross profit-$1.3M
Operating income-$8.8M
Net income-$9.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$7.5M
CapEx-$4.0M
Free cash flow-$11.6M
Total assets$22.7M
Total liabilities$5.8M
Total equity$16.9M
Cash & equivalents$3.9M
Long-term debt$2.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$16.9M
Net cash$1.7M
Current ratio2.3
Debt/Equity0.1
ROA-41.4%
ROE-55.7%
Cash conversion80.0%
CapEx/Revenue-12.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricNURIActivity
Op margin-2693.0%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-2879.5%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin-393.6%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1228.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity13.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 23:32 UTC#a7640330
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 23:34 UTCJob: 03b01459